NEW YORK (GenomeWeb) – OncoCyte said today that its Alameda, California clinical laboratory facility has received a CLIA certification of registration from the Centers for Medicare and Medicaid Services.

Certificates of registration allow labs to conduct moderate or high complexity testing ahead of being inspected for compliance with CLIA regulations, at which point they can receive a certificate of compliance.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.